Confronti finanziari Metropolis Healthcare Limited

Azioni

Prezzo di chiusura NSE India S.E. Altri mercati azionari 09/01/2026			Variaz. 5gg	Var. 1 gen.
1.920,40 ^INR	+0,22%		-0,67%	-0,44%

05/01	Crescita dei ricavi standalone di Metropolis Health al 15% su base annua	RE
06/11	Metropolis Healthcare Limited, Q2 2026 Earnings Call, Nov 06, 2025

Settore:

Regione:

Asse X:

Principali concorrenti

Aggiungi a un elenco 0 selezionato Solo clienti o iscritti possono usare questa funzione Accedi Registrati	Fatturato (Y-1)	Margine netto (Y-1)	Margine EBIT (Y-1)	ROE (Y-1)	ROA (Y-1)	Leverage (Y-1)
METROPOLIS HEALTHCARE LIMITED	156 Mln	10,89%	14,6%	11,95%	-	-0.11x
NATERA, INC.	1,7 Mrd	-11,22%	-13,1%	-19,42%	-13,87%	4.64x
SONIC HEALTHCARE LIMITED	6,32 Mrd	5,32%	9,43%	6,32%	3,33%	1.63x
RADNET, INC.	1,83 Mrd	0,15%	5,72%	0,29%	0,09%	0.99x
GENEDX HOLDINGS CORP.	305 Mln	-17,12%	3,15%	-	-	-3.46x
DR. LAL PATHLABS LIMITED	288 Mln	19,79%	22,49%	24,22%	18,83%	-1.45x
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	985 Mln	-5,3%	-3,8%	-4,9%	-3,44%	-1.84x
DIAN DIAGNOSTICS GROUP CO.,LTD.	1,67 Mrd	-2,93%	-0,26%	-5%	1,64%	1x
NEOGENOMICS, INC.	661 Mln	-11,92%	-13,94%	1,55%	-	6.02x
FLEURY S.A.	1,24 Mrd	8,02%	15,59%	11,88%	5%	1.54x
H.U. GROUP HOLDINGS, INC.	1,62 Mrd	1,14%	1,09%	2%	1,66%	1.56x
VIJAYA DIAGNOSTIC CENTRE LIMITED	79,74 Mln	21%	29,74%	19,7%	-	-0.85x
OPKO HEALTH, INC.	713 Mln	-7,46%	-21,33%	-	-	-
BML, INC.	956 Mln	4,37%	6,54%	4,9%	5,72%	-
NOVOGENE CO., LTD.	289 Mln	9,21%	10,97%	7,93%	5,44%	-
FULGENT GENETICS, INC.	283 Mln	-15,07%	-26,08%	1,32%	-	90.87x
THYROCARE TECHNOLOGIES LIMITED	80,44 Mln	-	-	-	-	-
SMO CLINPLUS CO.,LTD.	110 Mln	13,24%	15,14%	9,4%	7,62%	-
Media	1,07 Mrd	1,3%	3,29%	4,81%	2,91%	7,73x
Media ponderata per Capi.	1,89 Mrd	-4,74%	-3,37%	-7,36%	-6,08%	3,79x